Delivery Order SPE2DB20D2001-SPE2DB24FM46K

Award Date 2/22/24
Potential Completion Date 2/23/24
Potential Value $15K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order contract to Amerisourcebergen Drug Corp's Corporate Office division, worth $3,483.36, for the supply of 4565110247 TRULICITY 0.75 MG/0.5 ML PEN 0.5ML. This order is part of Amerisourcebergen's larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to...
The U.S. Defense Logistics Agency (DLA) has awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a firm fixed price delivery order contract valued at $5,805.60 to provide TRULICITY 0.75 MG/0.5 ML PEN 0.5ML pharmaceutical products. This order falls under a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00, which serves as the primary vehicle for Amerisourcebergen to deliver pharmaceuticals and medical supplies to DLA Troop Support Medical...
The Defense Logistics Agency (DLA) has awarded Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation, a firm fixed price delivery order contract valued at $8,172.60 to supply TRULICITY 0.75 MG/0.5 ML PEN 0.5ML pharmaceuticals. This delivery order is part of a larger indefinite delivery contract (IDC) awarded by DLA to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a performance period through December 31, 2025....
The Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a $1,995.78 firm fixed price delivery order contract to provide TRULICITY 0.75 MG/0.5 ML PEN 0.5ML, a specialty pharmaceutical product. This delivery order is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 that Amerisourcebergen Drug Corp holds with DLA to deliver a comprehensive range of pharmaceuticals and medical supplies to...
The U.S. Department of Defense's Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a firm fixed price delivery order contract to supply TRULICITY 0.75 MG/0.5 ML PEN 0.5ML, a specialty pharmaceutical product. The contract has a potential value of $1,607.84 and a performance period through February 27, 2024. Amerisourcebergen Drug Corp is the prime contractor on this award, which is not set aside for any specific business type. The...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the for-profit organization Amerisourcebergen Corporation, to provide the pharmaceutical product TRULICITY 1.5 MG/0.5 ML PEN 0.5ML. The contract has a potential value of $2,902.80 and a completion date of January 31, 2024. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, which is not associated with any set-aside designations....
The U.S. Defense Logistics Agency (DLA) Troop Support Medical has awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a firm-fixed-price delivery order contract valued at $3,073.82 to provide the pharmaceutical product TRULICITY 1.5 MG/0.5 ML PEN 0.5ML. This delivery order is part of a larger indefinite delivery contract (IDC) between DLA and Amerisourcebergen Drug Corp, valued up to $999,999,999.00, which serves as the primary vehicle for Amerisourcebergen to...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distributor. The $3,031.05 contract is for the delivery of TRULICITY 0.75 MG/0.5 ML PEN 0.5ML, a specialty pharmaceutical product, with a completion date of February 8, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA valued at up to $999,999,999.00 through...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the delivery of TRULICITY 3 MG/0.5 ML PEN 0.5ML. The contract has a potential value of $4,354.20 and a completion date of February 14, 2024. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, which is not associated with any set-aside designations. In addition, Amerisourcebergen Drug Corp holds an...
The Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract worth $3,483.36 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of Trulicity 0.75 mg/0.5 ml pens. This contract has a completion date of February 21, 2024. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, which is not associated with any set-aside designation. This award is part of a larger indefinite delivery contract (IDC) with a...
  • SPE2DB20D2001
    Indefinite Delivery Contract
  • SPE2DB20D2001-SPE2DB24FM46K
    Delivery Order

The Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a firm fixed price delivery order contract valued at $14,697.35 to provide TRULICITY 0.75 MG/0.5 ML PEN 0.5ML pharmaceuticals. The contract has a completion date of February 23, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with a potential value of $999,999,999.00 from DLA to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. This IDC does not have any set-aside designations and serves as the primary contract vehicle for Amerisourcebergen to provide these critical healthcare materials to military treatment programs worldwide.

Generated 5/23/24, 10:12 AM